The Influence of Interstitial Collagenas-1 Genotype Polymorphism on Colorectal Cancer Risk in Iranian Population

REFERENCES

• Arvelo F., Cotte C. Metalloproteinases in tumor progression. Invest Clin 2006; 47: 185–205
   PubMedGoogle Scholar
• Brinckerhoff C. E., Rutter J. L., Benbow U. Interstitial collagenase as marker of tumor progression. Clin Cancer Res 2000; 6: 4823–4830
   PubMed Web of Science ®Google Scholar
• Biondi M. L., Torri O., Leviti S., Seminati R., Cecchini F., Bernini M., Ghilardi G., Guagenellini E. MMP-1 and MMP-3 polymorphism in promoter region and cancer. Clin Chem 2000; 46: 2023–2024
   PubMed Web of Science ®Google Scholar
• Borden P., Heller R. A. Transcriptional control of matrix metalloproteinases and the tissue inhibitors of matrix metalloproteinases. Crit Rev Eukaryot Gene Expr 1997; 7: 159–178
   PubMed Web of Science ®Google Scholar
• Chambers A. F., Matrisian L. A. Changing views on the role of matrix metalloproteinases in metastasis. J Natl Cancer Inst 1997; 89: 1260–1270
   PubMed Web of Science ®Google Scholar
• Charles S. Extracellular matrix remodeling and cellular differentiation. Curr Opin Cell Biol 2003; 11: 634–640
   Google Scholar
• Chen B., Wen Y., Wang H., Polan M. L. Differences in estrogen modulation of tissue inhibitor of matrix metalloproteinase-1 and matrix metalloproteinase-1 expression in cultured fibroblasts from continent and incontinent women. Am J Obstet Gynecol 2003; 189: 59–65
   PubMed Web of Science ®Google Scholar
• Deryugina E. I., Quigley J. P. Matrix metalloproteinases and tumor metastasis. Cancer Metastasis Rev 2006; 25–934
   Google Scholar
• Fang S., Jin X., Wang R., Li Y., Guo W., Wang N., Wang Y., Wen D. W.L. Polymorphism in the MMP1 and MMP3 promoter and non-small lung carcinoma in north china. Carcinogenesis 2005; 6: 481–486
   Google Scholar
• Fingleton B. Matrix metalloproteinases as valid clinical targets. Curr Pharm 2007; 13: 333–46
   PubMed Web of Science ®Google Scholar
• Folgueras A. R., Pendás A. M., Sánches L. M., López C. Matrix metalloproteinases in cancer: from new function to improved inhibition strategies. Int J Dev Biol 2004; 48: 411–424
   PubMed Web of Science ®Google Scholar
• Ganea E., Trifan M., Laslo A. C., Putina G., Cristescu C. Matrix metalloproteinases: useful and deleterious. Biochem Soc Trans 2007; 35: 689–91
   PubMed Web of Science ®Google Scholar
• Ghilardi G., Biondi M. L., Mangoni J., Leviti S., DeMonti M., Guagnellini E., Scorza R. Matrix metalloproteinase-1 promoter polymorphism 1G/2G is correlated with colorectal cancer invasiveness. Clin Cancer Res 2001; 7: 2344–2346
   PubMed Web of Science ®Google Scholar
• Grant G. M., Cobb J. K., Castillo B., Klebe R. J. Regulation of matrix metalloproteinases following cellular transformation. J Cell Physiol 1996; 167: 177–183
   PubMed Web of Science ®Google Scholar
• Hijova E. Matrix metalloproteinases: their biological functions and clinical implications. Bratisl Lek Listy 2005; 131: 127–132
   Google Scholar
• Hirata H., Naito K., Yoshihiro S., Matsuyama H., Suehiro Y., Hinoda Y. A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter is associated with conventional renal cell carcinoma. Int J Cancer 2003; 106: 372–374
   PubMed Web of Science ®Google Scholar
• Johansson N., Ahonen M., Kähäri V.–M. Matrix metalloproteinases in tumor invasion. Cell Mol Life Sci 2000; 57: 5–15
   PubMed Web of Science ®Google Scholar
• John A., Tuszynsky G. The role of matrix metalloproteinase in tumor angiogenesis and tumor metastasis. Pathol Oncol Res 2001; 1: 14–23
   Google Scholar
• Kanamori Y., Matsushima M., Minaguchi T., Kobayashi K., Sagae S., Kudo R., Terakawa N., Nakamura Y. Correlation between expression of the matrix metalloproteinase-1 gene in ovarian cancers and an insertion/deletion polymorphism in its promoter region. Cancer Res 1999; 59: 4225–4227
   PubMed Web of Science ®Google Scholar
• Kemp Z., Thirlwell C., Sieber O., Silver A., Tomlinson L. An update on the genetics of colorectal cancer. Hum Mol Genet 2004; 13: 177–185
   Google Scholar
• Lemaître V., D'Armiento J. Matrix metalloproteinases in development and disease. Birth Defects Res C Embryo Today 2006; 78(1)1–10
   PubMedGoogle Scholar
• Matsumura S., Oue N., Kitadai Y. A single nucleotide polymorphism in the MMP-1 promoter is correlated with histological differentiation of gastric cancer. J Cancer Res Clin Oncol 2004; 10: 146–152
   Google Scholar
• Mengshol J. A., Mix K. S., Brinckerhoff C. E. Matrix metalloproteinases as therapeutic targets in arthritic diseases: bull's-eye or missing the mark Arthritis Rheum. 2002; 46: 13–20
   Google Scholar
• Miller S. A., Dybes D. D., Polesky H. F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988; 16: 1215
   PubMed Web of Science ®Google Scholar
• Nakopoulou L., Giannopoulou I., Gakiopoulou H., Liapis H., Tzonou A., Davaris P. S. Matrix metalloproteinase-1 and -3 in breast cancer: correlation with progesterone receptors and other clinicopathologic features. Hum Pathol 1999; 30: 436–442
   PubMed Web of Science ®Google Scholar
• Noël A., Jost M., Maquoi E. Matrix metalloproteinases at cancer tumor-host interface. Semin Cell Dev Biol 2008; 19: 52–60
   PubMed Web of Science ®Google Scholar
• Overall C. M., Kleifeld O. Towards third generation matrix metalloproteinase inhibitors for cancer therapy. Br J Cancer 2006; 94: 941–6
   PubMed Web of Science ®Google Scholar
• Rundhaug J. E. Matrix metalloproteinase and angiogenesis. J Cell Mol Med 2005; 9: 267–285
   PubMed Web of Science ®Google Scholar
• Rutter J. L., Mitchell T. I., Buttice G., Meyers J., Gusella J. F., Ozelius L. J., Brinckerhoff C. E. A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter creates an Ets binding site and augments transcription. Cancer Res 1998; 58: 5321–5325
   PubMed Web of Science ®Google Scholar
• Sato H. Tumor metastasis and MMP inhibitor. Clin Calcium 2006; 16: 621–626
   PubMedGoogle Scholar
• Singer C. F., Marbaix E., Kokorine I. The matrix metalloproteinase-1 (MMP-1) expression in the human endometrium is inversely regulated by interleukin-1 and sex steroids. Ceska Gynekol 2000; 65: 211–215
   PubMedGoogle Scholar
• Su L., Zhou W., Park S., Wain J., Lynch T., Liu G. Matrix metalloproteinase-1 promoter polymorphism and lung cancer risk. Cancer Epidemiol Prev 2005; 14: 567–570
   PubMed Web of Science ®Google Scholar
• Sunami E., Tsuno N., Osada T., Saito S., Kitayama J., Tomozava T., Shibata Y., Moto T., Nagava H. MMP-1 is a prognostic factor for hematogenous metastasis of colorectal cancer. Oncologist 2000; 5: 108–114
   PubMedGoogle Scholar
• Tower G. B., Coon C. I., Belguis K., Chalbos D., Brinkerhoff C. E. Fra-1 targets the AP-1 site/2G single nucleotide polymorphism (ETS site) in the MMP-1 promoter. Eur J Biochem 2003; 270: 4216–4225
   PubMedGoogle Scholar
• Verger A., Duterque-Coquillaud M. When ETS transcription factors meet their partners. Bio Essays 2002; 24: 362–370
   PubMed Web of Science ®Google Scholar
• Verma R. P., Hansch C. Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs. Bioorg Med Chem 2007; 15(6)2223–68
   PubMed Web of Science ®Google Scholar
• Vincenti M. P., Brinckerhoff C. E. The potential of signal transduction inhibitors for the treatment of arthritis: Is it all just JNK?. J Clin Invest 2001; 108: 181–183
   PubMed Web of Science ®Google Scholar
• Visse F., Nagase H. Structure and function of MMPs and TIMPs. Circulation Res 2003; 92: 827–839
   PubMed Web of Science ®Google Scholar
• Yan C., Boyd D. D. Regulation of matrix metalloproteinase gene expression. J Cell Physiol 2007; 211(1)19–26
   PubMed Web of Science ®Google Scholar
• Ye S., Dhillon S., Turner S. J., Bateman A. C., Theaker J. M., Pickering R. M., Day I., Howell W. M. Invasiveness of cutaneous malignant melanoma is influenced by matrix metalloproteinase 1 gene polymorphism. Cancer Res 2001; 61: 1296–1298
   PubMed Web of Science ®Google Scholar
• Yu C. Y., Pan K. F., Xing D. Y., Liang G., Tan W., Zhang L., Lin D. Correlation between a single nucleotide polymorphism in the matrix metalloproteinase-2 promoter and risk of lung cancer. Cancer Res 2002; 62: 6430–6433
   PubMed Web of Science ®Google Scholar
• Zhang J., Xia J., Fang S., Li Y., Wang R., Guo W., Wang Y., Wen D., Wei L., Kuang G., Dong Z. The functional SNP in the matrix metalloproteinase-3 promoter modifies susceptibility and lymphatic metastasis in esophageal squamous cell carcinoma but not in gastric cardiac adenocarcioma. Carcinogenesis 2004; 12: 2519–2524
   Google Scholar
• Zheng G., Cheng L. A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter enhances oral squamouse cell carcinoma susceptibility in a Chinese population. Oral Oncol 2006; 42: 32–38
   PubMed Web of Science ®Google Scholar
• Zhu Y., Spitz M. R., Lei L., Mills G. B., Wu X. A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter enhances lung cancer susceptibility. Cancer Res 2001; 61: 7825–7829
   PubMed Web of Science ®Google Scholar
• Zucker S., Vacirca J. Role of matrix metalloproteinase (MMPs) in colorectal cancer. Cancer Metas Rev 2004; 23: 101–117
   PubMed Web of Science ®Google Scholar